![]() |
市场调查报告书
商品编码
1715231
亚太地区初乳市场预测(至 2031 年)- 区域分析 - 按形态(干型和液态)、类别(传统型和有机型)和应用(药品和膳食补充剂、食品和饮料、动物营养和个人护理)Asia Pacific Colostrum Market Forecast to 2031 - Regional Analysis - by Form (Dry and Liquid), Category (Conventional and Organic), and Application (Pharmaceuticals and Dietary Supplements, Food and Beverages, Animal Nutrition, and Personal Care) |
2023年亚太地区初乳市值为4.4175亿美元,预计到2031年将达到7.6525亿美元;预计 2023 年至 2031 年的复合年增长率为 7.1%。
初乳加工技术进步推动亚太地区初乳市场发展
初乳透过各种製造流程广泛应用于功能性食品和饮料、药品和营养保健品、动物营养和个人护理产品。人们采用各种技术来保存和保护初乳中的重要生物活性因子。巴氏杀菌、灭菌等热处理方法及干燥方法是常用的技术。此外,製造商现在正在采用先进的技术来开发高营养的初乳。采用脂质体技术和奈米技术製备初乳供人类食用,具有多种健康益处。奈米技术是对超小尺度结构和材料的研究,它在从乳製品行业到医学等许多领域都有广泛的应用。奈米技术可以检测食品中的致病菌,确保食品的品质和安全。该技术因其优点(例如可以延长产品的保质期、改善食品的风味和质地)而越来越多地应用于食品市场。此外,该技术还具有显着的优势,可以避免保存初乳及其生物活性蛋白质的不稳定性问题。初乳蛋白(例如 IgG)的稳定性对于维持初乳的生物活性潜力至关重要。脂质体技术是一种常用的封装方法,广泛用于化妆品、製药和乳製品行业。这项先进技术使用脂质体,即包含至少一个脂质双层和磷脂的球形囊泡。脂质体可以具有表面配体,以确保各种配体的结合。脂质体技术已被用于保存初乳并提高其对人体健康的生物利用度。透过重建的膜磷脂将初乳输送到体内比没有经过脂质体包裹的初乳更有效,这使得该方法比其他常规方法更为先进。因此,初乳加工技术的进步预计将为全球初乳市场带来丰厚的成长机会。
亚太地区初乳市场概况
新加坡、印尼、泰国、马来西亚和纽西兰是亚太其他地区初乳市场的主要国家。由于强化食品、饮料和膳食补充剂越来越受欢迎,这些国家对初乳的需求预计将显着增长。由于消费者转向健康产品以及这些产品支出的增加,新加坡和马来西亚等国家的消费支出增加也支持了市场的成长。此外,个人护理和动物营养行业的成长进一步促进了该地区初乳市场的成长。
亚太地区初乳市场收入及预测(2031年)(百万美元)
亚太地区初乳市场细分
亚太地区初乳市场按形式、类别、应用和国家分类。
根据形态,亚太地区初乳市场分为干乳和液乳。 2023 年,干型饮料市场占有较大份额。
就类别而言,亚太地区初乳市场分为传统初乳和有机初乳。 2023 年,传统细分市场将占据更大的市场份额。
根据应用,亚太地区初乳市场分为药品和膳食补充剂、食品和饮料、动物营养和个人护理。 2023 年,药品和膳食补充剂领域占据了最大的市场份额。
依国家划分,亚太地区初乳市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023 年,亚太其他地区占据了亚太地区初乳市场份额的主导地位。
Titan Biotech Ltd、PanTheryx、Biodane Pharma A/S、Bionatin、Colostrum BioTec GmbH、Biostrum、Cure Nutraceutical PVT。 LTD.、INGREDIA sro、I. Livanou IKE 和 KERSIA GROUP 是初乳市场的一些领先公司。
The Asia Pacific colostrum market was valued at US$ 441.75 million in 2023 and is expected to reach US$ 765.25 million by 2031; it is estimated to register a CAGR of 7.1% from 2023 to 2031.
Technological Advancements in Colostrum Processing Boost Asia Pacific Colostrum Market
Colostrum is significantly used in functional food & beverages, pharmaceuticals & nutraceuticals, animal nutrition, and personal care products through various manufacturing processes. Various technologies are used to preserve and protect the significant bioactive factors in colostrum. Thermal treatment methods and drying methods such as pasteurization and sterilization are commonly used technologies. Moreover, manufacturers are now adopting advanced technologies to develop high nutrient-enriched colostrum. Liposomal technology and nanotechnology are used to prepare colostrum for human consumption with numerous health benefits. Nanotechnology is the study of structures and materials on an ultra-small scale, and it has various applications in many fields, from the dairy industry to medicine. Nanotechnology can detect food pathogens, which ensures the food quality and safety. This technology is increasingly used in the food market due to its advantages, such as improving the shelf life of products, flavor, and texture of foods. Additionally, this technology provides significant advantages to avoid instability problems in preserving colostrum and its bioactive proteins. The stability of colostrum proteins, such as IgG, is crucial to preserving the bioactive potential of colostrum. Liposomal technology is a commonly used encapsulation method widely preferred in the cosmetic, pharmaceutical, and dairy industries. This advanced technology uses a liposome, a spherical vesicle including at least one lipid bilayer and phospholipids. Liposomes can have surface ligands to ensure the binding of various ligands. Liposomal technology has been used to preserve colostrum and increase its bioavailability for human health. The delivery of colostrum through the body with the reconstituted membrane phospholipids is far more effective than the colostrum without liposomal encapsulation, making the method more advanced than other conventional methods. Thus, technological advancements in colostrum processing are projected to open lucrative growth opportunities in the colostrum market worldwide.
Asia Pacific Colostrum Market Overview
Singapore, Indonesia, Thailand, Malaysia, and New Zealand are among the major countries in the Rest of Asia Pacific colostrum market . The demand for colostrum in these countries is expected to witness significant growth owing to the growing popularity of fortified food and beverages and dietary supplements. Increasing consumer spending in countries such as Singapore and Malaysia owing to consumer shift toward healthy products and rising expenditure on these products are also supporting the market growth. In addition, the growth in the personal care and animal nutrition industries has further contributed to the growth of the colostrum market in the region.
Asia Pacific Colostrum Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Colostrum Market Segmentation
The Asia Pacific colostrum market is categorized into form, category, application, and country.
Based on form, the Asia Pacific colostrum market is bifurcated into dry and liquid. The dry segment held a larger market share in 2023.
In terms of category, the Asia Pacific colostrum market is bifurcated into conventional and organic. The conventional segment held a larger market share in 2023.
By application, the Asia Pacific colostrum market is segmented into pharmaceuticals and dietary supplements, food and beverages, animal nutrition, and personal care. The pharmaceuticals and dietary supplements segment held the largest market share in 2023.
By country, the Asia Pacific colostrum market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Rest of Asia Pacific dominated the Asia Pacific colostrum market share in 2023.
Titan Biotech Ltd, PanTheryx, Biodane Pharma A/S, Bionatin, Colostrum BioTec GmbH, Biostrum, Cure Nutraceutical PVT. LTD., INGREDIA s.r.o., I. Livanou IKE, and KERSIA GROUP are some of the leading companies operating in the colostrum market.